162 related articles for article (PubMed ID: 23604961)
21. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.
Atkins M; Coutinho AD; Nunna S; Gupte-Singh K; Eaddy M
J Med Econ; 2018 Feb; 21(2):212-217. PubMed ID: 29022427
[TBL] [Abstract][Full Text] [Related]
22. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
23. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
24. Skin cancer healthcare impact: A nation-wide assessment of an administrative database.
Duarte AF; Sousa-Pinto B; Freitas A; Delgado L; Costa-Pereira A; Correia O
Cancer Epidemiol; 2018 Oct; 56():154-160. PubMed ID: 30179829
[TBL] [Abstract][Full Text] [Related]
25. High incidence of skin cancer in the Channel Islands.
Reilly GD; Muhlemann M; Lai C; Verne J; Ives A; Southall PJ; Goulding H; Healy E
Clin Exp Dermatol; 2013 Apr; 38(3):239-43. PubMed ID: 22998572
[TBL] [Abstract][Full Text] [Related]
26. Effects of the German skin cancer screening programme on melanoma incidence and indicators of disease severity.
Trautmann F; Meier F; Seidler A; Schmitt J
Br J Dermatol; 2016 Nov; 175(5):912-919. PubMed ID: 27203791
[TBL] [Abstract][Full Text] [Related]
27. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
Reyes C; DaCosta Byfield S; Linke R; Satram-Hoang S; Teitelbaum AH
Melanoma Res; 2013 Apr; 23(2):159-66. PubMed ID: 23370422
[TBL] [Abstract][Full Text] [Related]
28. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Long MD; Martin CF; Pipkin CA; Herfarth HH; Sandler RS; Kappelman MD
Gastroenterology; 2012 Aug; 143(2):390-399.e1. PubMed ID: 22584081
[TBL] [Abstract][Full Text] [Related]
29. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis.
Amari W; Zeringue AL; McDonald JR; Caplan L; Eisen SA; Ranganathan P
Rheumatology (Oxford); 2011 Aug; 50(8):1431-9. PubMed ID: 21415022
[TBL] [Abstract][Full Text] [Related]
30. Skin cancers in Croatia, 2003-2005: epidemiological study.
Lipozencić J; Celić D; Strnad M; Toncić RJ; Pasić A; Rados J; Znaor A
Coll Antropol; 2010 Sep; 34(3):865-9. PubMed ID: 20977074
[TBL] [Abstract][Full Text] [Related]
31. Risk of non-melanoma skin cancer in autoimmune hepatitis.
Leung J; Dowling L; Obadan I; Davis J; Bonis PA; Kaplan MM; Casey D; Viveiros K
Dig Dis Sci; 2010 Nov; 55(11):3218-23. PubMed ID: 20165977
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and incidence of clinically significant patulous Eustachian tube: A population-based study using the Korean National Health Insurance Claims Database.
Choi SW; Kim J; Lee HM; Oh SJ; Lee IW; Goh EK; Kong SK
Am J Otolaryngol; 2018; 39(5):603-608. PubMed ID: 30025742
[TBL] [Abstract][Full Text] [Related]
33. Non-melanoma skin cancer: ten years of cancer-registry-based surveillance.
Kaldor J; Shugg D; Young B; Dwyer T; Wang YG
Int J Cancer; 1993 Apr; 53(6):886-91. PubMed ID: 8473047
[TBL] [Abstract][Full Text] [Related]
34. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019.
Aggarwal P; Knabel P; Fleischer AB
J Am Acad Dermatol; 2021 Aug; 85(2):388-395. PubMed ID: 33852922
[TBL] [Abstract][Full Text] [Related]
35. Incidence of childhood and adolescent melanoma in the United States: 1973-2009.
Wong JR; Harris JK; Rodriguez-Galindo C; Johnson KJ
Pediatrics; 2013 May; 131(5):846-54. PubMed ID: 23589817
[TBL] [Abstract][Full Text] [Related]
36. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort.
Abbas AM; Almukhtar RM; Loftus EV; Lichtenstein GR; Khan N
Am J Gastroenterol; 2014 Nov; 109(11):1781-93. PubMed ID: 25244964
[TBL] [Abstract][Full Text] [Related]
37. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
38. Trends of non-melanoma skin cancer incidence in Hong Kong and projection up to 2030 based on changing demographics.
Xu Q; Wang X; Bai Y; Zheng Y; Duan J; Du J; Wu X
Ann Med; 2023 Dec; 55(1):146-154. PubMed ID: 36519234
[TBL] [Abstract][Full Text] [Related]
39. The incidence of skin cancer in dermatology.
van der Geer S; Siemerink M; Reijers HA; Verhaegh ME; Ostertag JU; Neumann HA; Krekels GA
Clin Exp Dermatol; 2013 Oct; 38(7):724-9. PubMed ID: 24073653
[TBL] [Abstract][Full Text] [Related]
40. Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.
Mallone S; De Vries E; Guzzo M; Midena E; Verne J; Coebergh JW; Marcos-Gragera R; Ardanaz E; Martinez R; Chirlaque MD; Navarro C; Virgili G;
Eur J Cancer; 2012 May; 48(8):1167-75. PubMed ID: 22119735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
